• HLA-B27 Genotyping, Ankylosing Spondylitis
  • Gentamicin, Peak, Serum
  • Catecholamine Fractionation, Free, 24 Hour, Urine
  • Chronic Lymphocytic Leukemia (CLL) Monitoring, MRD Detection, Blood
  • Cutaneous Anaplastic Large Cell Lymphoma, 6p25.3 (IRF4) Rearrangement, FISH, Tissue
  • Aspergillus DNA, Qualitative, Real-Time PCR, Sputum
  • Chloride, Serum
  • Ureaplasma species, Molecular
  • Zolpidem, Serum
  • Vancomycin, Peak, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

References
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.